China Biologic Products Holdings Inc (CBPO) Return on Investment ROI from the fourth quarter of 2019 to fourth quarter of 2018 and for the year 2019, average high and low, overall ranking from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
China Biologic Products Holdings Inc   (NASDAQ: CBPO)


China Biologic Products Holdings Inc's ROI from its fourth quarter of 2019 to the fourth quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is China Biologic Products Holdings Inc's ROI in the fourth quarter of 2019?
China Biologic Products Holdings Inc achieved a return on average invested assets (ROI) of 8.95 % in its fourth quarter of 2019, which is below China Biologic Products Holdings Inc's average return on investment, which stands at 20.05%.

ROI has improved compared to 8.06% in the third quarter of 2019, due to net income growth.

Within the Healthcare sector 108 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2019 from 0 to 969.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2019)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Investment Change TTM -7.82 % 7.86 % 35.14 % 82.77 % 180.26 %
Y / Y Net Income Change TTM 10.43 % 79.93 % 79.93 % 79.93 % 79.93 %
Investment (TTM) in Millions 1,843 1,819 1,819 1,819 1,888
Return On Investment (TTM) 8.95 % 8.06 % 7.85 % 7.66 % 7.47 %
CBPO's Overall Ranking # 969 # 0 # 0 # 0 # 1620
Seq. Investment Change TTM -0.6 % -2.54 % -2.48 % -2.42 % 16.3 %
Seq. Net Income Change TTM 10.43 % 0 % 0 % 0 % 79.93 %
Net Income (TTM) in Millions 163 148 148 148 148

CBPO Company Profile >> Back to CBPO Roi Comparisons >> See Annual CBPO Return On Investment



Return On Investment CBPO's Ranking
Within: No.
Industry # 9
Sector # 109
Overall # 969

Return On Investment Statistics
High Average Low
26.34 %
20.05 %
7.36 %
(Jun 30 2015)   (Dec 31 2018)







Financial Statements
China Biologic Products Holdings Inc's IV. Quarter Investments $ 1,843 Millions CBPO's Balance sheet
China Biologic Products Holdings Inc's IV. Quarter Income $ 163 Millions Quarterly CBPO's Income Statement
CBPO's Income by Division See CBPO's Income by Division


CBPO Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 1,843 1,888 778 590 573
Y / Y Investment Growth -2.34 % 142.76 % 31.69 % 3.12 % 35.37 %
Net Income in Millions 163 148 82 129 114
Y / Y Net Income Growth 10.43 % 79.93 % -36.15 % 12.87 % 18.72 %
Annual Return On Investment 8.86 % 7.84 % 10.58 % 21.81 % 19.93 %


Annual Roi Comment
In the fiscal year 2019 ROI improved to 8.86 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CBPO's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CBPO's Competitors
Subscribers only: Roi for China Biologic Products Holdings Inc's Suppliers
Subscribers only: Return On Investment for CBPO's Customers

Other Ratios
CBPO's Roa CBPO's Inventory Turnover Ratio CBPO's Growth Rates CBPO's Dividend Statistics
CBPO's Profitability Ratios CBPO's Asset Turnover Ratio CBPO's Dividend Growth
CBPO's Roe CBPO's Valuation Ratios CBPO's Financial Strength Ratios CBPO's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2019, within Healthcare Sector ROI
Abiomed Inc   24.18 %
Chemed Corporation  23.17 %
Boston Scientific Corporation  22.36 %
Icon Plc  21.55 %
Biospecifics Technologies Corp  21.50 %
Arrowhead Pharmaceuticals Inc   21.42 %
Edwards Lifesciences Corporation  21.15 %
Exelixis Inc   20.27 %
Summit Therapeutics Inc   19.71 %
Vertex Pharmaceuticals Inc  19.36 %
Amgen Inc   19.24 %
Alpha Pro Tech Ltd   18.75 %
Fonar Corporation  18.09 %
Waters Corporation  17.93 %
Horizon Therapeutics Public Limited Company  17.75 %
Regeneron Pharmaceuticals Inc   17.75 %
Iradimed Corporation  17.58 %
Pro dex Inc   17.38 %
Masimo Corp  17.22 %
Intuitive Surgical Inc   17.17 %
Viemed Healthcare Inc   16.96 %
Alexion Pharmaceuticals Inc   16.92 %
Purple Biotech Ltd  16.81 %
Incyte Corporation  16.81 %
Abbvie Inc   15.88 %
Kamada Ltd   15.77 %
Ac Immune Sa  15.71 %
Merck and Co Inc   15.42 %
Illumina Inc   15.26 %
Atrion Corporation  15.25 %

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.